These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2667264)

  • 41. [Diagnosis and course of myocarditis: a survey in the medical clinics of Zurich University Hospital 1980 to 1998].
    Sauvant G; Bossart W; Kurrer MO; Follath F
    Schweiz Med Wochenschr; 2000 Sep; 130(36):1265-71. PubMed ID: 11028270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunosuppressive therapy for heart failure.
    Wojnicz R
    Heart Fail Clin; 2005 Oct; 1(3):449-56. PubMed ID: 17386867
    [No Abstract]   [Full Text] [Related]  

  • 43. [Myocardial disease in viral infections. Myocarditis--cardiomyopathy].
    Brehm M
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():36-9. PubMed ID: 16802516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is immunosuppressive treatment an option for myocarditis?
    Jonas M; Hod H
    Isr J Med Sci; 1997 Nov; 33(11):762-6. PubMed ID: 9434818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
    G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gamma-delta T-cell-mediated dilated cardiomyopathy.
    Takeda N; Seko Y; Oriuchi N; Nagai R
    Int J Cardiol; 2008 Mar; 125(1):130-2. PubMed ID: 17433841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of outcome in patients with suspected myocarditis.
    Kindermann I; Kindermann M; Kandolf R; Klingel K; Bültmann B; Müller T; Lindinger A; Böhm M
    Circulation; 2008 Aug; 118(6):639-48. PubMed ID: 18645053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of Coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease.
    Archard LC; Richardson PJ; Olsen EG; Dubowitz V; Sewry C; Bowles NE
    Biochem Soc Symp; 1987; 53():51-62. PubMed ID: 2847741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experience with immunosuppressive treatment of autoimmune myocarditis proven by myocardial biopsy].
    Högye M; Móczó I; Forster T; Edes I; Béres I; Szabó E; Tószegi A; Gaál T; Kovács G; Csanády M
    Orv Hetil; 1987 Mar; 128(9):451-7. PubMed ID: 3550587
    [No Abstract]   [Full Text] [Related]  

  • 50. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy.
    Matsumoto Y; Park IK; Kohyama K
    J Immunol; 2009 Oct; 183(7):4773-81. PubMed ID: 19734212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dilated cardiomyopathy in children.
    Gagliardi MG
    Acta Paediatr Suppl; 2006 Jul; 95(452):14-6. PubMed ID: 16801159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Myocarditis and dilated cardiomyopathy in children. Old questions-- new answers].
    Malcić I; Buljević AD
    Lijec Vjesn; 1999; 121(4-5):129-36. PubMed ID: 10437357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.
    Kawai C
    Circulation; 1999 Mar; 99(8):1091-100. PubMed ID: 10051305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Myocarditis and inflammatory cardiomyopathy].
    Mlejnek D; Krejčí J
    Vnitr Lek; 2017; 63(7-8):507-512. PubMed ID: 28933176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation].
    Kühl U; Pauschinger M; Schultheiss HP
    Internist (Berl); 1997 Jun; 38(6):590-601. PubMed ID: 9265004
    [No Abstract]   [Full Text] [Related]  

  • 56. Prognosis and treatment of cardiomyopathy and myocarditis.
    O'Connell JB; Costanzo-Nordin MR; Engelmeier RS; Wallis DE; Robinson JA; Scanlon PJ
    Heart Vessels Suppl; 1985; 1():175-9. PubMed ID: 3843581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunosuppressive therapy of chronic myocarditis in children: three cases and the design of a randomized prospective trial of therapy.
    Schmaltz AA; Demel KP; Kallenberg R; Neudorf U; Kandolf R; Klingel K; Bültmann B
    Pediatr Cardiol; 1998; 19(3):235-9. PubMed ID: 9568220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical aspects of myocarditis.
    Richardson PJ
    Heart Vessels Suppl; 1985; 1():97-100. PubMed ID: 3843597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy?
    Parrillo JE
    Circulation; 2001 Jul; 104(1):4-6. PubMed ID: 11435327
    [No Abstract]   [Full Text] [Related]  

  • 60. [Current concepts of diagnosis and therapy of myocarditis from the clinico-immunologic viewpoint].
    Hiepe F; Müller S; Förster A; Apostoloff E; Geissler W
    Z Arztl Fortbild (Jena); 1991 Jun; 85(12):547-50. PubMed ID: 1926923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.